Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

14 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q3 2022.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.25M shares of 384M outstanding shares and own 0.85% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.58M shares), Cormorant Asset Management, LP (288K shares), Ikarian Capital, LLC (246K shares), BOOTHBAY FUND MANAGEMENT, LLC (37.4K shares), STATE STREET CORP (28.6K shares), CITADEL ADVISORS LLC (21.2K shares), GEODE CAPITAL MANAGEMENT, LLC (11.7K shares), ENVESTNET ASSET MANAGEMENT INC (11.7K shares), Activest Wealth Management (7.6K shares), and ADVISOR GROUP HOLDINGS, INC. (6.99K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.